# Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment

> **NCT00809731** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 490 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00809731
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2010-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809731, "Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00809731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*